☆ 4.5 Article

COVID-19 vaccination for children with pulmonary hypertension: efficacy, safety and reasons for opting against vaccination

FRONTIERS IN PEDIATRICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pediatrics

Acceptability of COVID-19 vaccination in Chinese children aged 3-7 years with bronchopulmonary dysplasia

Dan Wang et al.

Summary: This study investigated the COVID-19 vaccination status and the influencing factors among Chinese children aged 3-7 years with bronchopulmonary dysplasia (BPD). The overall vaccination rate was 69.0%, with lower acceptance among children whose mothers had higher education, lived in urban areas, had low birth weight, a history of hospitalization for lung diseases, and intellectual disability. Kindergarten students and children from high-income families were more likely to accept vaccination. Adverse reactions were reported in 4.7% of the children. The main reasons for not accepting vaccination were concerns about adverse reactions and lack of convenience or knowledge of vaccination stations.

PEDIATRIC PULMONOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai

Dawei Yang et al.

Summary: The study found that inactivated COVID-19 vaccines offer some protection against symptomatic infections and reduce the risk of severe illness. However, the vaccines are not effective in preventing the community spread of the SARS-CoV-2 Omicron variant.

FRONTIERS IN MEDICINE (2023)

添加到收藏夹

Review Peripheral Vascular Disease

Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician

Diana L. Tobler et al.

Summary: This review consolidates available data on the long-term cardiovascular complications of COVID-19 infection. Acute cardiovascular complications include myocarditis, pericarditis, acute coronary syndrome, heart failure, pulmonary hypertension, right ventricular dysfunction, and arrhythmia. Long-term follow-up shows increased incidence of arrhythmia, heart failure, acute coronary syndrome, right ventricular dysfunction, myocardial fibrosis, hypertension, and diabetes mellitus. Future research is important in understanding the clinical significance of these structural abnormalities and evaluating the effect of vaccines on preventing long-term cardiovascular complications.

CURRENT ATHEROSCLEROSIS REPORTS (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Parent/guardian intentions to vaccinate children against COVID-19 in the United States

Don E. Willis et al.

Summary: Vaccination is crucial for protecting adults and children from COVID-19 infection. The study found that intentions to vaccinate children are influenced by factors such as age, gender, race/ethnicity, education, political affiliation, social norms, and COVID-19 vaccine hesitancy.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

添加到收藏夹

Article Medicine, General & Internal

Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID)

Ekaterina Pazukhina et al.

Summary: A significant proportion of COVID-19 patients experience post-COVID-19 condition (PCC) symptoms even 6 and 12 months after discharge, with females, individuals with pre-existing hypertension in adults, and those with neurological comorbidities or allergic respiratory diseases in children being at higher risk.

BMC MEDICINE (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Analysis of potential risk factors associated with COVID-19 and hospitalization

Abdul-Hakeem Moazi Alharbi et al.

Summary: Complications of COVID-19 are associated with factors such as gender, age, comorbidity, and race. Male gender, age over 60, and unvaccinated patients with comorbidities increase the risk of hospitalization.

FRONTIERS IN PUBLIC HEALTH (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)

Marc Humbert et al.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Editorial Material Respiratory System

The COVID-19 pandemic and pulmonary arterial hypertension in Italy: adaptation, outcomes and valuable lessons learned

Claudia Mickael et al.

EUROPEAN RESPIRATORY JOURNAL (2022)

添加到收藏夹

Article Environmental Sciences

Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain

Narmeen Mallah et al.

Summary: Research shows that COVID-19 booster vaccines can significantly increase protection against SARS-CoV-2 infection, especially in older age groups and those with various medical conditions.

ENVIRONMENTAL RESEARCH (2022)

添加到收藏夹

Review Infectious Diseases

Risk factors for Covid-19 severity and fatality: a structured literature review

Dominik Wolff et al.

Summary: A systematic literature review on the risk factors of severe and fatal Covid-19 courses shows that conditions and comorbidities related to poor health status, high age, obesity, diabetes, and hypertension are risk factors for severe and fatal disease courses. Additionally, organ damage and coagulation dysfunctions are associated with severe and fatal courses of the disease.

INFECTION (2021)

添加到收藏夹

Article Respiratory System

Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study

Tak Kyu Oh et al.

Summary: This study investigated the impact of chronic respiratory diseases (CRDs) on the risk and mortality of COVID-19 in the South Korean population. Results showed that patients with interstitial lung disease (ILD) and obstructive sleep apnea (OSA) had a higher incidence of COVID-19, while patients with COPD and chronic lung disease due to external agents had a higher risk of mortality among patients with COVID-19.

BMC PULMONARY MEDICINE (2021)

添加到收藏夹

Review Immunology

Interrelations between COVID-19 and other disorders

Amin Gasmi et al.

Summary: COVID-19 caused by SARS-CoV-2 can range from asymptomatic carriers to severe acute respiratory distress syndrome. Patients with comorbidities such as hypertension, diabetes, and chronic obstructive pulmonary disease are at higher risk of severe symptoms and poor prognosis.

CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study

Erjia Ge et al.

Summary: The study revealed that comorbidities play a significant role in the mortality and severity of COVID-19 patients, with a higher number of comorbidities associated with increased risks. Specifically, comorbidities were found to have a greater impact on younger individuals, emphasizing the importance of prioritizing vaccination for younger populations with multiple comorbidities.

PLOS ONE (2021)

添加到收藏夹

Article Immunology

COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination

Maria Wieteska-Milek et al.

Summary: The incidence of COVID-19 infection in patients with PAH and CTEPH is similar to that in the general population, but the mortality rate is higher. COVID-19 vaccination is recommended for these patients. Some patients refused vaccination due to concerns about adverse events and age had an impact on willingness to be vaccinated. Adverse events were more common in younger patients, but the vaccines were overall considered safe for PAH/CTEPH patients.

VACCINES (2021)

添加到收藏夹

Article Pediatrics

Outcomes of COVID-19 infection in pediatric pulmonary hypertension: A single-center experience

Raysa Morales-Demori et al.

Summary: In a single-center experience at Texas Children's Hospital, COVID-19 infection was more frequently observed in Hispanic patients and was associated with low mortality.

PEDIATRIC PULMONOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients

Susan M. Taghioff et al.

Summary: This study analyzed data from over 73 million patients to investigate the potential benefits of influenza vaccination in reducing adverse outcomes in SARS-CoV-2 positive patients. Results showed that receiving the influenza vaccine was associated with decreased risks of sepsis, stroke, ICU admissions, deep vein thrombosis (DVT), and emergency department visits in SARS-CoV-2 positive patients. Further prospective studies are needed to explore this potential protective effect.

PLOS ONE (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study

Jesus Castilla et al.

Summary: This prospective study in Spain found that certain demographic factors and chronic conditions were associated with higher risks of SARS-CoV-2 infection, hospitalization, and death. It identified groups such as the older population, nursing home residents, and individuals with specific health conditions as priorities for COVID-19 prevention and vaccination. The study also highlighted the need for additional support for immigrants in terms of preventive measures.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19

Matteo Pagnesi et al.

HEART (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?

Jinglu Lyu et al.

MEDICAL HYPOTHESES (2020)

添加到收藏夹

Letter Respiratory System

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey

Catharina Belge et al.

ERJ OPEN RESEARCH (2020)

添加到收藏夹

Article Respiratory System

A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care

Joshua D. Lee et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT

Georg Hansmann et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)

添加到收藏夹

Article Respiratory System

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

Gerald Simonneau et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.